文献速递神经肌肉病认知障碍与痴呆

肌萎缩侧索硬化与额颞叶痴呆具有不同的临床前血液生化特征

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles.
PubMed 文献 · Ann Neurol · 2025-10-30

基于英国初级保健数据库的人群队列研究显示,较高LDL-C和总胆固醇水平与ALS风险线性相关,而较高肌酐与FTD风险降低相关,HbA1c与FTD呈U形关联。研究提示两种疾病的临床前生化标志物存在差异。

要点

  • 较高LDL-C和总胆固醇与ALS风险升高线性相关。
  • 较高肌酐与FTD风险降低相关,且获孟德尔随机化支持。
  • HbA1c与FTD风险呈U形关联。

核心结论

  • LDL-C和总胆固醇可能反映ALS早期疾病变化或病因,肌酐和HbA1c可能与FTD相关。

研究设计与样本

  • 基于英国QResearch初级保健记录与医院统计链接的人群队列研究,纳入1998至2023年有生物标志物数据的成人。
  • 采用Cox比例风险模型估计关联,并应用两样本孟德尔随机化探索遗传预测的关联。

主要发现

  • 随访期间诊断ALS up to 2,695例,FTD 781例,中位随访分别为9.4年和10.5年。
  • LDL-C每升高1-SD,ALS风险HR=1.07(95%CI 1.02-1.11);总胆固醇每升高1-SD,HR=1.06(95%CI 1.02-1.10)。
  • ≥60岁人群总胆固醇与ALS关联更强(HR per 1-SD=1.08,95%CI 1.04-1.13,P交互=0.003)。
  • 肌酐每升高1-SD,FTD风险HR=0.90(95%CI 0.83-0.97);MR支持OR IVW per 1-SD=0.73(95%CI 0.56-0.96)。
  • HbA1c与FTD呈U形关联(P非线性=0.006)。

临床怎么用

  • 临床解读血脂、肌酐和HbA1c时,可分别关注其与ALS或FTD的潜在关联。
  • 对高龄人群总胆固醇与ALS的关联需结合年龄分层理解。
  • 上述标志物尚不能作为靶向预防或干预策略的依据。

局限性

  • 原文指出需在单基因ALS和FTD中进一步研究,以确定这些生物标志物是否可用于靶向预防或干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Identifying modifiable factors influencing amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) risk is important for prevention. Blood biomarkers, particularly cholesterol, have been associated with neurodegenerative risk, but findings in ALS are inconsistent, and data on FTD are limited. METHODS: We conducted a population-based cohort study using UK primary care records from QResearch linked with Hospital Episode Statistics. Adults with biomarker data recorded between 1998 and 2023 were included. We examined associations of low- and high-density lipoprotein cholesterol (LDL-C and HDL-C), total cholesterol, triglycerides, creatinine, creatine kinase, and HbA1c with ALS and FTD risk. Cox proportional hazards models were used to estimate associations. Two-sample Mendelian randomization (MR) was applied to explore genetically predicted associations of selected biomarkers. RESULTS: There were up to 2,695 ALS and 781 FTD diagnoses, with a median follow-up duration of 9.4 and 10.5 years, respectively. Higher LDL-C (hazard ratio [HR]per 1-SD = 1.07, 95% confidence interval [CI] = 1.02-1.11) and total cholesterol levels (HRper 1-SD = 1.06, 95% CI = 1.02-1.10) were linearly associated with higher ALS risk. Age-stratified analysis showed a stronger association for total cholesterol in those ≥ 60 years (HRper 1-SD = 1.08, 95% CI = 1.04-1.13, Pinteraction = 0.003). Higher creatinine was inversely associated with FTD risk (HRper 1-SD = 0.90, 95% CI = 0.83-0.97), supported by MR (odds ratio [OR] inverse variance weighted (IVW), per 1-SD = 0.73, 95% CI = 0.56-0.96). HbA1c showed a U-shaped association with FTD (Pnon-linearity = 0.006). INTERPRETATION: LDL and total cholesterol may provide insights into early disease changes or the etiology of ALS, whereas creatinine and HbA1c may be relevant for FTD. Research in monogenic ALS and FTD is needed to determine whether these biomarkers inform targeted prevention or intervention strategies. ANN NEUROL 2026;99:844-856.

来源:Ann Neurol,查看原文。版权归原作者所有。

引用

  1. Chalitsios CV, Gao J, Coupland CAC, et al. Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Have Distinct Prediagnostic Blood Biochemical Profiles. Ann Neurol. 2025. PMID: 41165081. doi:10.1002/ana.78082

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。